Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Rating of “Moderate Buy” from Brokerages

Schrödinger, Inc. (NASDAQ:SDGR) has been assigned an average recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $32.60.

Several brokerages have commented on SDGR. BMO Capital Markets cut their target price on Schrödinger from $30.00 to $25.00 and set an “outperform” rating on the stock in a research note on Thursday, October 17th. KeyCorp lowered their target price on shares of Schrödinger from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, July 11th. Finally, Morgan Stanley dropped their price target on shares of Schrödinger from $43.00 to $30.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 21st.

Schrödinger Stock Performance

Shares of NASDAQ SDGR opened at $17.99 on Monday. The company has a 50 day simple moving average of $18.96 and a two-hundred day simple moving average of $20.72. The company has a market capitalization of $1.31 billion, a price-to-earnings ratio of -6.71 and a beta of 1.50. Schrödinger has a fifty-two week low of $16.67 and a fifty-two week high of $38.00.

Schrödinger (NASDAQ:SDGR) last announced its quarterly earnings results on Wednesday, July 31st. The company reported ($0.74) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.85) by $0.11. The company had revenue of $47.33 million for the quarter, compared to analysts’ expectations of $40.19 million. Schrödinger had a negative net margin of 100.42% and a negative return on equity of 38.38%. On average, analysts forecast that Schrödinger will post -2.19 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Schrödinger news, insider Margaret Dugan sold 1,531 shares of the stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total value of $27,221.18. Following the transaction, the insider now directly owns 13,469 shares in the company, valued at approximately $239,478.82. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 8.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Schrödinger

Several hedge funds and other institutional investors have recently modified their holdings of SDGR. Vanguard Group Inc. increased its position in Schrödinger by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 6,776,631 shares of the company’s stock worth $242,603,000 after buying an additional 77,830 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in Schrödinger by 186.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company’s stock worth $76,000 after acquiring an additional 1,385 shares during the period. Baillie Gifford & Co. raised its stake in Schrödinger by 0.4% during the 1st quarter. Baillie Gifford & Co. now owns 2,612,007 shares of the company’s stock worth $70,524,000 after acquiring an additional 9,618 shares during the period. GSA Capital Partners LLP lifted its holdings in Schrödinger by 127.7% during the first quarter. GSA Capital Partners LLP now owns 39,604 shares of the company’s stock valued at $1,069,000 after purchasing an additional 22,210 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in shares of Schrödinger by 70.2% in the first quarter. Geneos Wealth Management Inc. now owns 37,126 shares of the company’s stock worth $1,002,000 after purchasing an additional 15,310 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.